4.9App Store rating
1M+meals logged

Melatonin research, what the studies found.

Sleep onset, dose, label accuracy and safety, read from the original studies.Last reviewed Nov 18, 2026

Clay still life of a plump pillow, a mug of warm milk, a bowl of oatmeal, a small plain supplement jar and a crescent moon on a soft blue tabletop
Studies
7
People studied
28K
Trials and reviews
6
Last reviewed
Nov 18, 2026

The short answer

In trials, melatonin shortens the time to fall asleep by about 5 to 6 minutes. Of 25 gummy products tested, 22 were inaccurately labeled. Safety data at higher doses and in children are limited.

What the studies cover

Evidence at a glance

  • Time to fall asleep

    About 5 to 6 minutes faster than placebo in adults with insomnia (prolonged-release form).

    Helps a littleVery strong

    Studies: Dec 2023Aug 2024

  • Total sleep time

    Longer total sleep across 26 trials, with the effect peaking at 4 mg a day

    Helps a littleModerate

    Study: Aug 2024

  • Parkinson's disease

    One 8-week trial of 73 adults found better sleep scores on 3 mg

    Too early to sayModerate

    Study: Dec 2024

  • Children

    Faster sleep onset in 167 children with neurologic conditions; none in typical children

    Too early to sayModerate

    Study: Jan 2026

  • Side effects at 10 mg or more

    In 4 low-risk trials, no detectable rise in serious events; more drowsiness, headache and dizziness

    No clear effectModerate

    Study: Mar 2022

Strength comes from study design and how many studies back the row. Observational studies show links, not cause.

The basics

Overview

What is melatonin?

Melatonin is a hormone the body makes in the evening. It is also sold as a supplement, and every trial here tested supplements, not foods. Products come as prolonged-release tablets, gummies and other forms.

What does the research show?

A meta-analysis of 22 trials found prolonged-release melatonin shortened sleep onset by about 5 to 6 minutes versus placebo. A dose-response analysis of 26 trials found the effect peaking at 4 mg per day. One 8-week trial of 73 adults with Parkinson's disease found better sleep scores on 3 mg.

More questions (2)

What are the drawbacks or open questions?

Of 25 gummy brands tested, 22 were inaccurately labeled, with measured melatonin from 74% to 347% of the label amount. At 10 mg or more, serious adverse events showed no detectable rise, but drowsiness, headache and dizziness were more frequent. Child data come only from children with neurologic conditions.

What does it mean for your plate?

None of these trials tested foods. Evening meals such as oatmeal, and drinks such as warm milk, were not studied here.

2021 to 2026

The studies

Each one is dated and linked to the paper. Tap details for the people studied and the abstract line.

  • JAMA

    Of 25 melatonin gummy brands tested, 22 were inaccurately labeled. Measured melatonin ranged from 74% to 347% of the label amount.

    Cross-sectional studyEarly signal
    Show detailsHide details

    25 melatonin gummy products bought online, tested in 2022

    Twenty-two of 25 products (88%) were inaccurately labeled, and only 3 products (12%) contained a quantity of melatonin within ±10% of the declared quantity.

    On your plateMelatonin products are sold as dietary supplements, and this paper tested gummies only.

    Read the paperPubMed

  • Journal of Pineal Research

    Melatonin shortened the time to fall asleep and lengthened total sleep across 26 trials, with the effect peaking at 4 mg per day.

    Meta-analysis of RCTsVery strong
    Show detailsHide details

    26 trials, 1,689 observations, trials published 1987 to 2020

    Dose-response meta-analysis showed that melatonin gradually reduces sleep onset latency and increases total sleep time, peaking at 4 mg/day.

    On your plateThe trials tested melatonin supplements, not foods or evening routines.

    Read the paperPubMed

  • Journal of Sleep Research

    Prolonged-release melatonin shortened the time to fall asleep by about 5 to 6 minutes versus placebo, a small to medium effect.

    Meta-analysis of RCTsVery strong
    Show detailsHide details

    22 trials, 4,875 adults (925 on melatonin), mostly short trials

    Compared with placebo, PR melatonin appears efficacious with a small to medium effect size on subjective sleep onset latency (sSOL) (p = 0.031; weighted difference = -6.30 min), objective sleep onset latency (oSOL) (p < 0.001; weighted difference = -5.05 min), and objective sleep efficiency (oSE) (p = 0.043; weighted difference = 1.91%).

    On your plateThese trials used prolonged-release melatonin supplements, not foods.

    Read the paperPubMed

See all 7 studies
  • Sleep Medicine Reviews

    Across 69 trials, orexin receptor blockers beat melatonin receptor drugs for sleep latency. Melatonin receptor drugs may still help sleep-onset insomnia.

    Meta-analysis of RCTsVery strong

    69 trials, 17,319 adults with insomnia, trials to March 2022

    Orexin receptor antagonists (ORAs) are more efficacious than benzodiazepine-like drugs (Z-drugs) and placebo for WASO and SE, and better than melatonin receptor agonists (MRAs) for SL, WASO and SE.

    On your plateThis review compared medicines, not foods or supplements.

    Read the paperPubMed

  • Sleep Medicine

    Over 8 weeks, 3 mg melatonin improved sleep scores versus placebo in adults with Parkinson's disease. The authors doubt it applies widely.

    Randomized trialModerate

    73 completers (86 randomized) with Parkinson's disease, 8 weeks

    The mean change in Pittsburgh Sleep Quality Index (PSQI) score between the two groups was 1.87 (95 % CI: 1.5-2.1; p = 0.001) and Epworth Sleepiness Scale (ESS) score was 1.25 (95 % CI: 0.80-1.71; p = 0.001) favoring melatonin.

    On your plateThis trial tested a 3 mg melatonin supplement in Parkinson's disease, not a food.

    Read the paperPubMed

  • JAMA Network Open

    Trials in 167 children with neurologic conditions reported faster sleep onset and few adverse events. No efficacy data exist for typically developing children.

    Systematic reviewModerate

    19 articles, 167 children in the trials, trials averaged 12.7 weeks

    The trials included 167 young children with neurologic conditions and lasted a mean of 12.7 weeks (range, 2 weeks to 2 years). For effectiveness, trials provided evidence for improved sleep onset in young children with neurologic conditions (eg, autism spectrum disorder), with few adverse events.

    On your plateThis review covered supplement use, not foods. Its observational data also documented rising overdoses in young children.

    Read the paperPubMed

  • Journal of Pineal Research

    In 4 low-risk-of-bias trials at 10 mg or more, melatonin showed no detectable rise in serious adverse events. Drowsiness, headache and dizziness were more frequent.

    Meta-analysis of RCTsVery strong

    79 trials, 3,861 adults, doses of 10 mg or more

    In that small subset, melatonin did not cause a detectable increase in SAEs (Rate Ratio = 0.88 [0.52, 1.50], p = .64) or withdrawals due to AEs (0.93 [0.24, 3.56], p = .92), but did appear to increase the risk of AEs such as drowsiness, headache and dizziness (1.40 [1.15, 1.69], p < .001).

    On your plateThese trials gave melatonin supplements, not foods.

    Read the paperPubMed

Dots rate the study design and size, from early signal to very strong.

Everyday foods

On your plate

  • OatmealOatmealA common evening bowl; not tested in these trials
  • Warm milkWarm milkA common bedtime drink; not tested in these trials
  • BananaBananaA light evening snack; not tested in these trials

Make it yours

Research is general. Alma builds yours.

  • Meals fit to your goal and the foods you like
  • Log a meal by photo, voice or text in about 10 seconds
  • Every meal gets an Alma Score from 0 to 100
A clay cup of green tea with blueberries and walnuts

Questions

What else do people ask?

Does melatonin help you fall asleep faster?

Trials show a small gain. A 22-study meta-analysis found prolonged-release melatonin shortened sleep onset by about 5 to 6 minutes versus placebo. A dose-response analysis of 26 trials found the effect peaking near 4 mg per day.

Do melatonin labels match what is inside?

In a 2023 JAMA analysis of 25 gummy products, 22 were inaccurately labeled and measured melatonin ranged from 74% to 347% of the label. Tablets and capsules were not tested, and each brand was sampled once.

What is the 2025 heart failure signal?

A large health record study at the 2025 American Heart Association Scientific Sessions reported a heart failure signal with long-term melatonin use in adults with insomnia. A 2026 Open Heart paper using NHANES 1999 to 2018 found no significant link and called it hypothesis-generating.

Is higher-dose melatonin safe?

In the few low-risk-of-bias trials at 10 mg or more, serious adverse events showed no detectable rise. Drowsiness, headache and dizziness were more frequent. Long-term data are limited, so the evidence is early.

Parents of young children, pregnant people, and anyone with heart failure or on regular medicines should ask a clinician or pharmacist about melatonin. Alma does not advise on supplements.

Sources

Written by Alma from the papers below and last reviewed Nov 18, 2026. Each study was checked against its PubMed or journal record. This is general information, not medical advice. If you manage a health condition or take medication, check changes with your clinician. Editorial standards

  1. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US JAMA, Apr 2023. DOI PubMed 37097362
  2. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis Journal of Pineal Research, Aug 2024. DOI PubMed 38888087
  3. Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and meta-analysis Journal of Sleep Research, Dec 2023. DOI PubMed 37434463
  4. Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis Sleep Medicine Reviews, Apr 2023. DOI PubMed 36701954
  5. Melatonin on sleep in Parkinson's disease: A randomized double blind placebo controlled trial Sleep Medicine, Dec 2024. DOI PubMed 39437460
  6. Melatonin Use in Young Children: A Systematic Review JAMA Network Open, Jan 2026. DOI PubMed 41481289
  7. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis Journal of Pineal Research, Mar 2022. DOI PubMed 34923676
  8. NIH NCCIH: Melatonin, what you need to know
  9. 2026 Open Heart paper: melatonin and cardiovascular risk (NHANES)

Get a week built around you.

Tell Alma your goal and the foods you like. It plans the meals and scores each one.